Application 050444
- Type
- NDA
- Sponsor
- REMPEX PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MINOCIN | MINOCYCLINE HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 100MG BASE/VIAL | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 54531-100 | Minocin | minocycline hydrochloride | Rempex Pharmaceuticals, Inc | NDA | Current |
| 65293-014 | Minocin | minocycline hydrochloride | The Medicines Company | NDA | Current |
| 65293-014 | Minocin | minocycline hydrochloride | The Medicines Company | NDA | Current |
| 65293-014 | Minocin | minocycline hydrochloride | The Medicines Company | NDA | Current |
| 70842-160 | Minocin | minocycline hydrochloride | Melinta Therapeutics, Inc | NDA | Current |
| 70842-160 | Minocin | minocycline hydrochloride | Melinta Therapeutics, Inc | NDA | Current |
| 70842-160 | Minocin | minocycline hydrochloride | Melinta Therapeutics, Inc | NDA | Current |
| 70842-160 | Minocin | minocycline hydrochloride | Melinta Therapeutics, LLC | NDA | Current |
| 70842-160 | Minocin | minocycline hydrochloride | Melinta Therapeutics, LLC | NDA | Current |
| 70842-160 | Minocin | minocycline hydrochloride | Melinta Therapeutics, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 81849 | SUPPL | 2025-04-08 |
| 81784 | SUPPL | 2025-03-31 |
| 17834 | SUPPL | 2015-04-22 |
| 17833 | SUPPL | 2014-11-18 |
| 30028 | SUPPL | 2014-10-27 |
| 38941 | SUPPL | 2010-09-20 |
| 7753 | SUPPL | 2010-09-17 |
| 17832 | SUPPL | 2007-01-18 |
| 7752 | SUPPL | 2007-01-18 |
| 7751 | SUPPL | 2005-10-20 |
| 38940 | SUPPL | 2005-09-30 |
| 7749 | SUPPL | 2005-02-17 |
| 42642 | SUPPL | 2004-06-29 |
| 30027 | SUPPL | 2004-06-01 |
| 7750 | SUPPL | 2004-06-01 |
| 7748 | SUPPL | 2002-05-31 |
| 30026 | SUPPL | 2002-01-30 |
| 30025 | SUPPL | 2002-01-30 |
| 7747 | SUPPL | 2002-01-30 |